Philippe Gruet - Vetoquinol Chief Officer

All Insiders . France . 
Stock . Vetoquinol . Stakeholders . Insider . Philippe Gruet
VETO Stock  EUR 77.80  0.40  0.51%   

Insider

Philippe Gruet is Chief Officer of Vetoquinol
Phone33 3 84 62 55 55
Webhttps://www.vetoquinol.com

Vetoquinol Management Efficiency

The company has return on total asset (ROA) of 0.0774 % which means that it generated a profit of $0.0774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.11 %, meaning that it generated $0.11 on every $100 dollars invested by stockholders. Vetoquinol's management efficiency ratios could be used to measure how well Vetoquinol manages its routine affairs as well as how well it operates its assets and liabilities.
Vetoquinol has accumulated 7.07 M in total debt with debt to equity ratio (D/E) of 1.8, which is about average as compared to similar companies. Vetoquinol has a current ratio of 3.19, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Vetoquinol until it has trouble settling it off, either with new capital or with free cash flow. So, Vetoquinol's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vetoquinol sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vetoquinol to invest in growth at high rates of return. When we think about Vetoquinol's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Michel FreicheTrigano SA
62
MarieHlne FeuilletTrigano SA
74
Sandrine BrunelVirbac SA
N/A
Fabienne BochetThermador Groupe SA
49
Xavier IsaacThermador Groupe SA
54
Patricia MavignerThermador Groupe SA
55
Eric MantioneThermador Groupe SA
64
Marc BistuerVirbac SA
N/A
Isabelle PardiesRobertet SA
N/A
Stphane GigouTrigano SA
50
Lionel MonroeThermador Groupe SA
56
Habib RamdaniVirbac SA
46
Olivier MaubertRobertet SA
58
JeanDaniel DorRobertet SA
N/A
Jerome ChabaudieThermador Groupe SA
58
Bertrand HavrileckVirbac SA
N/A
Christian KarstVirbac SA
64
Nathalie PolletVirbac SA
N/A
Sophie FaviniVirbac SA
N/A
Christophe MaubertRobertet SA
64
Guillaume RobinThermador Groupe SA
58
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people. Vetoquinol (VETO) is traded on Euronext Paris in France and employs 2,621 people.

Management Performance

Return On Equity0.11
Return On Asset0.0774

Vetoquinol Leadership Team

Elected by the shareholders, the Vetoquinol's board of directors comprises two types of representatives: Vetoquinol inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vetoquinol. The board's role is to monitor Vetoquinol's management team and ensure that shareholders' interests are well served. Vetoquinol's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vetoquinol's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthieu Frechin, CEO, Director and Member of Strategy Committee
Hans Hollegien, Member of the Executive Committee, Group Director - Marketing and Communication
Philippe Gruet, Chief Officer
Isabelle ProustCabrera, Member of the Executive Committee, Group Director - Human Resources
Xavier Berthet, Director Communications
Laurent Thore, Legal Partnerships
Dominique Derveaux, Member of the Executive Committee, Group Director - Europe
Regis Monteil, Group Director of Fin. and Legal
Sandrine Perrier, Chief Officer
Alain Masson, COO and Chief Pharmacist

Vetoquinol Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vetoquinol a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.11
Return On Asset0.0774
Profit Margin0.09 %
Operating Margin0.14 %
Current Valuation938.81 M
Shares Outstanding11.88 M
Shares Owned By Insiders66.90 %
Shares Owned By Institutions15.84 %
Price To Earning20.18 X
Price To Book2.25 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in Vetoquinol Stock

Vetoquinol financial ratios help investors to determine whether Vetoquinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vetoquinol with respect to the benefits of owning Vetoquinol security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY